Article
[Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3].
Zeitschrift fur Gastroenterologie - 1 Jun 2003
Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns M P
Abstract excerpt
Patients with chronic hepatitis C infected with HCV genotype 2 and 3 can be successfully treated in more than 80 % of cases. It had been shown that a 24 week t.i.w. treatment period with standard interferon alpha and ribavirin is sufficient for these patients. However, the recent multicenter studies investigating the effect of pegylated interferons and ribavirin used a 48 week schedule for all patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.